News

Warnex’s Medical Laboratories division will develop pharmacogenetic assays and serve as a central laboratory for several clinical studies of Schering-Plough Canada.

Dr Aslam will be responsible for all ongoing development programmes within Enigma, with emphasis on Enigma’s rapid diagnostics systems.

The agreement recognizes Illumina’s technology and development expertise with Mayo Clinic’s utility to establish new diagnostic technologies.

The project funding $15M, will occur in Scotland with over 40 new jobs created in the universities, and 50 new jobs projected for the core laboratory.

The new entity named Siemens Medical Solutions Diagnostics is a wholly owned subsidiary of Siemens Medical Solutions USA.

Fisher HealthCare to access Luminex xMAP® technology while Luminex gains access to major diagnostic sales network.

GenVault issued rights to dry-state sample archiving, using carriers designed to store dried biosamples as discrete, individually addressable aliquots.

The compound developed by UCLA, called FDDNP, holds promise as a research tool to evaluate treatments for Alzheimer's.

Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.

EMR solution integrates clinical data with patient-specific information in a move towards personalized medicine for cancer patients.